Skip to main content

Research Repository

Advanced Search

miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review

Abdalla, Mohammed; Deshmukh, Harshal; Atkin, Stephen L.; Sathyapalan, Thozhukat

Authors

Mohammed Abdalla

Stephen L. Atkin



Abstract

© 2020 Elsevier Inc. Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in females of the reproductive age. PCOS is commonly manifested as ovulatory dysfunction, clinical and biochemical excess androgen level, and polycystic ovaries. Metabolic sequelae associated with PCOS, including insulin resistance (IR), type 2 diabetes (T2DM), obesity and increased cardiometabolic risk. The underlying pathology of PCOS is not fully understood with various genetic and environmental factors have been proposed. MicroRNAs (miRNAs), are endogenously produced, small non-coding, single-stranded RNAs that capable of regulating gene expression at the post-transcriptional level. Altered miRNAs expression has been associated with various disorders, including T2DM, IR, lipid disorder, infertility, atherosclerosis, endometriosis, and cancer. Given that PCOS also present with similar features, there is an increasing interest to investigate the role of miRNAs in the diagnosis and management of PCOS. In recent years, studies have demonstrated that miRNAs are present in various body fluids, including follicular fluid of women with PCOS. Therefore, it may act as a potential biomarker and could serve as a novel therapeutic target for the diagnosis and treatment of PCOS. This review aims to summarise the up to date research on the relation between miRNAs and PCOS and explore its potential role in the diagnosis and the management of PCOS.

Citation

Abdalla, M., Deshmukh, H., Atkin, S. L., & Sathyapalan, T. (2020). miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review. Life Sciences, 259, https://doi.org/10.1016/j.lfs.2020.118174

Journal Article Type Review
Acceptance Date Jul 27, 2020
Online Publication Date Aug 1, 2020
Publication Date Oct 15, 2020
Deposit Date Oct 29, 2020
Publicly Available Date Aug 2, 2021
Journal Life Sciences
Print ISSN 0024-3205
Electronic ISSN 1879-0631
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 259
DOI https://doi.org/10.1016/j.lfs.2020.118174
Keywords Polycystic ovary syndrome; PCOS; microRNA; miRNAs; Biomarkers; T2DM; Infertility; Follicular development; Lipid metabolism; Hyperandrogenism
Public URL https://hull-repository.worktribe.com/output/3600136
Publisher URL https://www.sciencedirect.com/science/article/abs/pii/S0024320520309267?via%3Dihub

Files







You might also like



Downloadable Citations